↓ Skip to main content

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
twitter
8 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley